NCT03319563

Brief Summary

Since the first spinal fusion by Hibbs 1911, yet anesthesia for correction of scoliosis is challenging due to frequently associated co-morbidities, the extensive nature of surgery and liability for many complications. Among the major concerns for anesthesiologists are the pain and bleeding. Scoliosis correction accounts for massive blood loss that may exceed more than half of blood volume. There are many strategies for blood conservation; however sometimes some of them may not be suitable. For analgesia, the most frequently loco regional analgesic techniques in spine surgery are intrathecal, epidural or local infiltration techniques. infiltration data reviled inconclusive and heterogeneous results. Our purpose is to optimize blood conservation and analgesia through anatomically based modification of the infiltration technique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 11, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2017

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

October 11, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 24, 2017

Completed
Last Updated

October 26, 2020

Status Verified

October 1, 2020

Enrollment Period

6 months

First QC Date

October 11, 2017

Last Update Submit

October 22, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Estimated blood loss

    milliliter

    Intraoperative

  • Total Morphine consumption.

    milligram

    during first 24 hours postoperatively.

Secondary Outcomes (26)

  • The surgical field visualization for subcutaneous incision

    Intraoperative, 10 minutes after skin incision.

  • The surgical field visualization for muscular dissection

    Intraoperative, 30 minutes after the thoracolumbar fascia incision,

  • The surgical field visualization for nails insertion

    Intraoperative, 30 minutes after the first nail insertion.

  • The surgical field visualization for osteotomy

    Intraoperative, 20 minutes after the first osteotomy

  • The operative duration

    Intraoperative

  • +21 more secondary outcomes

Study Arms (2)

local anesthetic-epinephrine group

EXPERIMENTAL

after general anesthesia, the Infiltration cocktail was done by the surgeon at three levels: 1. Subcutaneous: before incision at a volume 20 ml/10 cm/side. 2. Muscular Paravertebral: before opening the thoracolumbar fascia, using the same previous volume. 3. Neural paravertebral: after exposure of the transverse processes. A volume of 5 ml/per each process of the same cocktail, 1 cm deep to the surface of the corresponding process before pedicular screws fixation after negative blood aspiration.

Drug: Local anesthetic-epinephrine

saline group

PLACEBO COMPARATOR

after general anesthesia, the same infiltration volume and technique using normal saline.

Drug: Saline

Interventions

* Bupivacaine 0.5% (Astra Zeneca) 2 mg/Kg. * Lidocaine 5 mg/Kg. * Epinephrine 5 mcg/ml of the total volume. * Add normal saline to a total volume of 100 ml/10 cm of the wound length.

Also known as: infiltration group
local anesthetic-epinephrine group
SalineDRUG

normal saline 100 ml/10 cm of the wound length

Also known as: control group
saline group

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Kyphoscoliosis patients subjected for spinal correction.
  • Age 8-18 years.
  • American Society of Anesthesiologists I-II status.

You may not qualify if:

  • Patient or parents refusal.
  • Infection at surgical site.
  • Hypersensitivity to amide local anesthetics.
  • Coagulopathy.
  • Blood diseases as sickle cell anemia, hemophilia, idiopathic thrombocytopenic purpura.
  • Sever cardiac, respiratory, renal or hepatic impairment.
  • Presence of communication barrier.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University Hospital and Delta Hospital

Al Mansurah, Dakahlya, 35516, Egypt

Location

MeSH Terms

Interventions

Sodium ChlorideControl Groups

Intervention Hierarchy (Ancestors)

ChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium CompoundsEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor of anesthesia and surgical intensive care

Study Record Dates

First Submitted

October 11, 2017

First Posted

October 24, 2017

Study Start

April 11, 2017

Primary Completion

October 10, 2017

Study Completion

October 10, 2017

Last Updated

October 26, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will share

after publication

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
no limits
Access Criteria
e mail: alaa\ mazy@yahoo.com

Locations